아시아 태평양 e-Clinical Solutions 시장 – 2030년까지의 산업 동향 및 예측

아시아 태평양 e-Clinical Solutions 시장 분석 및 규모

아시아 태평양 e-임상 솔루션 시장은 Oracle, IQVIA Inc., Dassault Systemes, Clario 등과 같은 많은 글로벌 기업으로 구성되어 있기 때문에 본질적으로 분산되어 있습니다. 이러한 기업의 존재는 지역 전체에서 시스템 서비스 및 소프트웨어에 대한 경쟁력 있는 가격을 제공합니다. 지역 및 국제 수준에서 이러한 기업이 존재하기 때문에 공급업체와 제조업체는 모든 예산에서 다양한 사양과 특성을 가진 제품을 제공합니다. 전자 데이터 캡처(EDC) 시스템 및 클라우드 기반 솔루션의 채택이 증가함에 따라 시장 성장이 촉진되고 있습니다. 또한 환자 중심 임상 시험에 대한 집중이 커지면서 시장 성장이 촉진될 것으로 예상됩니다.

Data Bridge Market Research는 아시아 태평양 e-임상 솔루션 시장이 2030년까지 2,867.92백만 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 12.9%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.

Market Definition

The goal of e-clinical solutions is to revolutionize the field of clinical research. The clinical management organization is trying to improve the effectiveness, efficiency, and accessibility of clinical research data to treat patients more quickly. The idea behind the creation of eClinical Solutions was to pinpoint the problems with clinical research data, fix them, and offer creative solutions to make clinical trial data useful and simple to obtain, as well as to facilitate the standardization, reporting, and operation of the clinical research domain. The rising adoption and growing focus towards the e clinical solutions and software are expected to drive market growth.

 The e-clinical solutions, such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF) systems, are software programs used in clinical research to manage clinical data. However, strict regulations and standards for the approval of clinical trial studies and product approvals are expected to restrain market growth.

Asia-Pacific e-Clinical Solutions Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increasing R&D activities and corresponding expenditure

Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.

The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.

Improved healthcare infrastructure and establishment of advanced laboratories

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.

Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.

OPPORTUNITY

 Increasing investments by various governments in clinical trials

Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.

RESTRAINT / CHALLENGE

Data Safety and Privacy issues

Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.

Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the Asia-Pacific e-clinical solutions market and is expected to hamper market growth.

Post-COVID-19 Impact on the Asia-Pacific e-Clinical Solutions Market

The COVID-19 created a positive impact on the Asia-Pacific e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.

However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.

Recent Developments

• In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
• In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering

Asia-Pacific e-Clinical Solutions Market Scope

The Asia-Pacific e-clinical solutions market is segmented into six notable segments based on product, delivery mode, clinical trial phase, organization size, user device, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product

• Electronic Data Capture and Clinical Data Management Systems
• Clinical Trial Management Systems
• Clinical Analytics Platforms
• Care Coordination Medical Record (CCMR)
• Randomization and Trial Supply Management
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment Solutions
• Safety Solutions
• Electronic Trial Master File  Systems
• Regulatory Information Management Solutions
• Others

Based on product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems,  clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions, and others.

Delivery Mode

• Web-Hosted (On-Demand) Solutions
• Licensed Enterprise (On-Premises) Solutions
• Cloud-based (SAAS) Solutions

Based on delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.

Clinical Trial Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Based on clinical trial phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.

Organization Size

• Small & Medium
• Large

Based on organization size, the market is segmented into small & medium and large.

User Device

• Desktop
• Tablet
• Handheld PDA Device
• Smart Phone
• Others

Based on user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.

End User

• Pharmaceutical and Biopharmaceutical companies
• Contract Research Organizations
• Consulting Service Companies
• Medical Device Manufacturers
• Hospitals
• Academic Research Institutes

Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.

Asia-Pacific e-Clinical Solutions Market Regional Analysis/Insights

The Asia-Pacific e-clinical solutions market is analyzed, and market size information is based on product, delivery mode, clinical trial phase, organization size, user device, and end user.

The countries covered in this market report are China, Japan, India, South Korea, Australia, Singapore, Thailand,  Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.

Japan is expected to dominate the Asia-Pacific region due to the rising adoption of electronic data capture systems and cloud-based solutions.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 추세에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제와 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 아시아 태평양 E-Clinical Solutions 시장 점유율 분석

아시아 태평양 e-임상 솔루션 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 세부 정보에는 회사 개요, 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우위가 포함됩니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

아시아 태평양 e-임상 솔루션 시장에서 활동하는 주요 기업으로는 Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions LLC 등이 있습니다.

SKU-47901